Xia Wang, M.D., Ph.D., is a clinical geneticist with accreditations from the American Board of Medical Genetics (ABMG) and the American Board of Internal Medicine (ABIM). She also has considerable experience in the fields of molecular biology, biochemistry and genomics. She has more than 15 years of clinical experience in genetic conditions, including cancer genetics. Her work focuses on evaluation of hereditary cancer, interpretation of genetic test results, cancer screening for individuals with hereditary risk, and comprehensive care for individuals with complex hereditary tumor syndromes, such as Neurofibromatosis, Tuberose Sclerosis, Cowden syndrome and von Hippel-Lindau disease.
Dr. Wang provides comprehensive care for patients with Neurofibromatosis (NF). She has created and directs the first multi-disciplinary neurofibromatosis clinic in Florida dedicated to adult patients. Besides clinical care, Dr. Wang also engages in researches aimed at advancing the strategies to monitor, screen and optimize the timing of intervention for hereditary cancer/tumor syndromes. She is one of the first contributed to the research in characterizing breast cancer in Neurofibromatosis type 1 (NF1). She has studied the breast cancer risk and germline genomic profiling of women with NF1 who developed breast cancer. She has analyzed the breast cancers from women with NF1 and found germline and somatic NF1 alterations are linked to increased HER2 expression in breast cancer.
Tampa, FL, USA
Geneticist
Cancer Geneticist
H. Lee Moffitt Cancer Center and Research Institute